ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

ASM

415

-0.65%↓

UPM.FI

22.75

+1.74%↑

AKZA

54.68

+1%↑

STERV.FI

9.13

+1.67%↑

IDR

36.6

+1.5%↑

Search

Kemira Oyj

Chiusa

18.95 1.07

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

18.72

Massimo

18.99

Metriche Chiave

By Trading Economics

Entrata

58M

119M

Vendite

-15M

693M

P/E

Media del settore

13.207

114.478

EPS

0.35

Rendimento da dividendi

3.84

Margine di Profitto

17.191

Dipendenti

4,851

EBITDA

-8.2M

135M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

3.84%

3.39%

Utili prossimi

24 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

29M

3B

Apertura precedente

17.88

Chiusura precedente

18.95

Kemira Oyj Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 ago 2025, 21:42 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Utili
I principali Market Mover

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Utili

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

I principali Market Mover

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Discorsi di Mercato

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Utili

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Utili

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Utili

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Utili

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Discorsi di Mercato

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Discorsi di Mercato

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Discorsi di Mercato

Gold Climbs on Rate Cut Speculation -- Market Talk

Confronto tra pari

Modifica del prezzo

Kemira Oyj Previsione

Notizie finanziarie

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Kemira Oyj

Kemira Oyj operates as a chemicals company in Finland, rest of Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates in two segments, Pulp & Paper and Industry & Water. The Pulp & Paper segment develops and commercializes pulp and paper, as well as a range of products for paper wet-end, including packaging, and board and tissue products. The Industry & Water segment offers coagulants, polymers, and other water treatment chemicals. Kemira Oyj was founded in 1920 and is headquartered in Helsinki, Finland.